67 WALL STREET, New York - August 8, 2014 - The Wall Street Transcript has just published its Medical Devices Report offering a timely review of the sector to serious investors and industry executives. This special feature contains expert industry commentary through in-depth interviews with public company CEOs and Equity Analysts. The full issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.
Topics covered: Orthopedics and Cardiovascular Medical Devices - Medical Device Innovation and Consolidation Trends - Affordable Care Act - Aging U.S. Population - Medical Technology Innovation - Medical Equipment Growth Opportunities - Efficient Patient Treatment - Bifurcation in Medical Devices
Companies include: The Spectranetics Corporation (SPNC) and many more.
In the following excerpt from the Medical Devices Report, the CEO and the CFO of The Spectranetics Corporation (SPNC) discuss company strategy and the outlook for this vital industry:
TWST: You had revenues of $158.8 million in fiscal year 2013, which is an increase of 13% from 2012 when the company reached $140.3 million in that fiscal year. Can you talk about the breakdown of that revenue and where the growth is coming from?
Mr. Childs: In 2013, 87% of our revenue consisted of single-use medical devices, and that's comprised of vascular intervention devices and lead management devices. The mix within these two is about 55% vascular, about 45% lead management. So the remainder of our business is comprised of 10% laser rental and service, which is another form of recurring revenue. And then rounded out by the sale of laser systems, which represents 3% of revenue.
TWST: Can you break down revenues last year by geographic region, and can you indicate where growth is coming from?
Mr. Childs: About 20% of our business is outside the U.S., mostly in Europe followed by Japan. Both are growing, but Japan is the fastest-growing segment of the international business.
TWST: You had a net loss in 2013 after expenses. Can you explain that?
For more of this interview and many others visit the Wall Street Transcript - a unique service for investors and industry researchers - providing fresh commentary and insight through verbatim interviews with CEOs, portfolio managers and research analysts. This special issue is available by calling (212) 952-7433 or via The Wall Street Transcript Online.